Mayo Clinic will limit coverage for weight loss drugs through its employee health plan starting in 2024, the Post Bulletin reported Nov. 11. The Mayo Medical Plan, administered by Medica, will ...

Rochester, Md.-based Mayo Clinic has announced a partnership with leading pharmaceutical manufacturer Baxter and the biotech arm of Velocity Pharmaceutical Development, a bioscience development ...

The Mayo Clinic Biobank is a collection of samples, including blood and blood derivatives, and health information donated by Mayo Clinic patients. Seventy-seven genes known to be involved in drug ...

Mayo Clinic’s Florida campus in Jacksonville will receive $12 million and manage the distribution of the remaining grant to its collaborators in the study. The experimental drug is called ibudilast.

In a statement, Mayo Clinic said it will continue to provide coverage of these weight loss medications through the employee medical plan "with a new provision that reflects a lifetime maximum ...

Study involving investigators from Mayo Clinic, Baylor College of Medicine applies drug-gene testing to improve patient care and reports outcomes Peer-Reviewed Publication Mayo Clinic ...

Mayo Clinic Health System in Eau Claire is trying to make it easier for cancer patients with its drug repository program. The initiative, which is began in 2020, is part of larger program in ...

The two drugs together resulted in greater anti-cancer activity in ATC than either drug alone, says lead researcher Keith Bible, M.D., Ph.D., a Mayo Clinic oncologist.

“The Mayo Clinic-developed ADNIC platform is a perfect fit for our extensive G-MAB antibody products including but not limited to our anti-PD-L1, anti-CD38, anti-BCMA and anti-ROR1 antibodies.